Results

311 - 320 of 321 results for ‘guidelines’.

  • Avian influenza

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/avian-influenza

    ... Whole genome sequencing identification of an avian influenza virus. Laboratory suggestive evidence: Confirmation of an influenza A infection by polymerase chain reaction (PCR) testing but further subtyping for confirmation of avian influenza has not been possible. Laboratory testing guidelines Expand all Purpose of testing Purpose of testing Laboratory confirmation should be urgently sought to confirm all cases under investigation. Testing of asymptomatic people for avian influenza virus infection is not routinely recommended. Public health service responsibilities for testing Publi ...

  • Medical Certificate of Cause of Death

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/burial-and-cremation-act-1964/completing-death-documents/medical-certificate-of-cause-of-death

    ... malignant, or indeterminate. If malignant, the notes on cancer should be applied; otherwise the site and type of tumour should be given.   See example: Cancer 3. Assisted Dying 3. Assisted Dying For a death that was assisted under the End of Life Choice Act 2019 please follow these guidelines when completing the Cause of death section of the Medical Certificate of Cause of Death (HP4720 form) Select the ‘Assisted Dying’ checkbox, if completing the form online in   Death Documents (external link) . This will populate Part 1(a) of the certificate with the words ‘Assisted D ...

  • 13. Meningococcal disease

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/13-meningococcal-disease

    ... should be clearly noted on information accompanying the patient to hospital. Table 13.2: Recommended antibiotics for suspected cases Table 13.2: Recommended antibiotics for suspected cases Check The New Zealand Formulary (external link) for up to date dosing details, as well as the Starship guidelines (external link) .  Antibiotic Children <30kg Children >30kg and Adults (max dose) Ceftriaxone a (first line treatment) 50 mg/kg when given by GP/primary care 100 mg/kg IV (or IM) up to 2g when given in ED 2 g IV (or IM) Benzylpenicillin b (second choice) 50 mg/kg IV (or IM) 2.4 g IV ...

  • The National Bowel Screening Programme Key documents

    http://tewhatuora.govt.nz/health-services-and-programmes/national-bowel-screening-programme/key-documents

    ... Aotearoa's response to the Bowel Cancer Screening campaign in 2023 [PDF, 13 MB] Developing a campaign baseline Developing a campaign baseline Developing a campaign baseline [PDF, 9.9 MB] Publications Find a range of information on bowel screening, from strategies and plans, to clinical guidelines. Bowel screening publications (external link)

  • Psychosocial screening

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/diseases-and-conditions/stroke/httpnsn-squarespace-compsychosocial-toolkitscreening

    ... by a stroke but can also be a sign of mood changes. If concerns are raised: If concerns are raised: Acknowledge and normalise concerns, be empathetic, and provide a sense of hope Discuss with team and with whānau if consenting. Consider structured mood screens or risk assessments (see guidelines below) Consider referrals to mental health clinicians and/or cultural or spiritual support. Document any concerns and actions For practical strategies and examples see below sections on Communication following psychosocial screening and Action Plans to Support Well-being. Screening with struct ...

  • 25. Zoster (herpes zoster/shingles)

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/25-zoster-herpes-zostershingles

    ... to three months for the use of rZV in individuals who are immunocompromised with an increased risk of zoster recurrence or prior to planned immunosuppression.  25.6. Contraindications and precautions See   section 2.1.3 (external link)   for pre-vaccination screening guidelines and   section 2.1.4   for general contraindications for all vaccines. Expand all 25.6.1. Contraindications 25.6.1. Contraindications Recombinant rZV (Shingrix) is contraindicated to individuals with a history of hypersensitivity to a previous dose or to any component of the va ...

  • 20. Rotavirus

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/immunisation-handbook/20-rotavirus

    ... by vaccine exposure during pregnancy. There is no restriction for breastfeeding before or after vaccination of the infant (see ‘ Shedding (external link) ’ in section 20.6.2 ). 20.6. Contraindications and precautions See   section 2.1.3   for pre-vaccination screening guidelines and  section 2.1.4   for general contraindications for all vaccines. Expand all 20.6.1. Contraindications 20.6.1. Contraindications Rotavirus vaccine should not be given to infants with: a history of a severe (anaphylactic) allergic reaction after a previous dose or to a vacci ...

  • COVID-19: Infection prevention and control recommendations for health and disability care workers

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/covid-19/information-for-health-professionals/infection-prevention-and-control-recommendations-for-health-and-disability-care-workers

    ... 14 February 2022   Types of P2/N95 particulate respirators There are different types of P2/N95 particulate respirators. Below are some useful links to manufacturer’s information to help don and fit check a P2/N95 particulate respirator correctly. Always refer to the manufacturer’s guidelines.      Note not all brands, make or model below may be available. This is not an endorsement of any brand, make or model, but provides guidance on how to don and fit check the different styles of respirators.      Manufacturers guidance on donning and fit checking: 3M 18 ...

  • 14. Mpox (orthopoxvirus)

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/14-mpox

    ... Two doses of MPV are recommended, particularly for individuals with immunocompromise including well-controlled HIV infection, regardless of smallpox (vaccinia) vaccination history. 14.6. Contraindications and precautions See also section  ‎ 2.1.3 for pre-vaccination screening guidelines and section  ‎ 2.1.4 for general contraindications for all vaccines. Expand all 14.6.1. Contraindications 14.6.1. Contraindications MPV is contraindicated for anyone with a severe systemic allergic reaction (anaphylaxis) to a previous dose or any component of the vaccine, including ...

  • 16. Pertussis (whooping cough)

    http://tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/16-pertussis-whooping-cough

    ... adults with a medical condition, not eligible for funded vaccine, who are at increased risk of severe consequences of pertussis (eg, those with chronic respiratory disease). 16.6. Contraindications and precautions See also   section 2.1.3   for pre-vaccination screening guidelines and   section 2.1.4 (external link)   for general contraindications for all vaccines. Expand all 16.6.1. Contraindications 16.6.1. Contraindications The only contraindication is an immediate severe anaphylactic reaction to the vaccine, or any component of the vaccine, followin ...